Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.
Réus GZ, de Moura AB, Borba LA, Abelaira HM, Quevedo J. Réus GZ, et al. Among authors: Abelaira HM. Mol Neuropsychiatry. 2019 Oct;5(4):178-189. doi: 10.1159/000500324. Epub 2019 May 21. Mol Neuropsychiatry. 2019. PMID: 31768371 Free article. Review.
Animal models as tools to study the pathophysiology of depression.
Abelaira HM, Réus GZ, Quevedo J. Abelaira HM, et al. Braz J Psychiatry. 2013;35 Suppl 2:S112-20. doi: 10.1590/1516-4446-2013-1098. Braz J Psychiatry. 2013. PMID: 24271223 Review.
The role of mTOR in depression and antidepressant responses.
Abelaira HM, Réus GZ, Neotti MV, Quevedo J. Abelaira HM, et al. Life Sci. 2014 Apr 17;101(1-2):10-4. doi: 10.1016/j.lfs.2014.02.014. Epub 2014 Feb 25. Life Sci. 2014. PMID: 24582593 Review.
MAPK signaling correlates with the antidepressant effects of ketamine.
Réus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, Carlessi AS, Neotti MV, Matias BI, Luz JR, Dal-Pizzol F, Quevedo J. Réus GZ, et al. J Psychiatr Res. 2014 Aug;55:15-21. doi: 10.1016/j.jpsychires.2014.04.010. Epub 2014 Apr 18. J Psychiatr Res. 2014. PMID: 24819632
Animal models of social anxiety disorder and their validity criteria.
Réus GZ, Dos Santos MA, Abelaira HM, Quevedo J. Réus GZ, et al. Life Sci. 2014 Sep 26;114(1):1-3. doi: 10.1016/j.lfs.2014.08.002. Epub 2014 Aug 15. Life Sci. 2014. PMID: 25132362 Review.
Cognitive dysfunction in depression: lessons learned from animal models.
Reus GZ, Abelaira HM, Leffa DD, Quevedo J. Reus GZ, et al. CNS Neurol Disord Drug Targets. 2014;13(10):1860-70. doi: 10.2174/1871527313666141130223453. CNS Neurol Disord Drug Targets. 2014. PMID: 25470404 Review.
Ketamine treatment partly reverses alterations in brain derived- neurotrophic factor, oxidative stress and energy metabolism parameters induced by an animal model of depression.
Réus GZ, Nacif MP, Abelaira HM, Tomaz DB, dos Santos MA, Carlessi AS, Matias BI, da Luz JR, Steckert AV, Jeremias GC, Scaini G, Morais MO, Streck EL, Quevedo J. Réus GZ, et al. Curr Neurovasc Res. 2015;12(1):73-84. doi: 10.2174/1567202612666150122122924. Curr Neurovasc Res. 2015. PMID: 25613382
A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation.
Réus GZ, Carlessi AS, Titus SE, Abelaira HM, Ignácio ZM, da Luz JR, Matias BI, Bruchchen L, Florentino D, Vieira A, Petronilho F, Quevedo J. Réus GZ, et al. Dev Neurobiol. 2015 Nov;75(11):1268-81. doi: 10.1002/dneu.22283. Epub 2015 Mar 19. Dev Neurobiol. 2015. PMID: 25728399
Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas.
Réus GZ, Dos Santos MA, Abelaira HM, Titus SE, Carlessi AS, Matias BI, Bruchchen L, Florentino D, Vieira A, Petronilho F, Ceretta LB, Zugno AI, Quevedo J. Réus GZ, et al. Diabetes Metab Res Rev. 2016 Mar;32(3):278-88. doi: 10.1002/dmrr.2732. Epub 2015 Nov 11. Diabetes Metab Res Rev. 2016. PMID: 26432993
49 results
Jump to page
Feedback